Geode Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-910,599
| Closed | -$36.1M | – | 4664 |
|
|
2024
Q1 | $36.1M | Buy |
910,599
+146,252
| +19% | +$4.32M | ﹤0.01% | 1575 |
|
|
2023
Q4 | $14.6M | Buy |
764,347
+135,422
| +22% | +$1.88M | ﹤0.01% | 2103 |
|
|
2023
Q3 | $7.2M | Buy |
628,925
+10,951
| +2% | +$135K | ﹤0.01% | 2452 |
|
|
2023
Q2 | $6.35M | Buy |
617,974
+61,767
| +11% | +$557K | ﹤0.01% | 2564 |
|
|
2023
Q1 | $4.29M | Buy |
556,207
+70,457
| +15% | +$561K | ﹤0.01% | 2701 |
|
|
2022
Q4 | $3.57M | Buy |
485,750
+234,246
| +93% | +$1.5M | ﹤0.01% | 2835 |
|
|
2022
Q3 | $1.81M | Buy |
251,504
+3,512
| +1% | +$28.9K | ﹤0.01% | 3116 |
|
|
2022
Q2 | $2.11M | Buy |
247,992
+32,836
| +15% | +$283K | ﹤0.01% | 3093 |
|
|
2022
Q1 | $1.93M | Buy |
215,156
+18,490
| +9% | +$160K | ﹤0.01% | 3279 |
|
|
2021
Q4 | $2.72M | Buy |
196,666
+2,645
| +1% | +$32.8K | ﹤0.01% | 3219 |
|
|
2021
Q3 | $2.07M | Buy |
194,021
+2,483
| +1% | +$22.9K | ﹤0.01% | 3330 |
|
|
2021
Q2 | $1.72M | Buy |
191,538
+99,396
| +108% | +$1.08M | ﹤0.01% | 3330 |
|
|
2021
Q1 | $976K | Buy |
92,142
+14,915
| +19% | +$186K | ﹤0.01% | 3573 |
|
|
2020
Q4 | $973K | Buy |
77,227
+30,145
| +64% | +$296K | ﹤0.01% | 3382 |
|
|
2020
Q3 | $413K | Buy |
47,082
+8,308
| +21% | +$76K | ﹤0.01% | 3482 |
|
|
2020
Q2 | $376K | Buy |
38,774
+1,338
| +4% | +$5.79K | ﹤0.01% | 3468 |
|
|
2020
Q1 | $107K | Hold |
37,436
| – | – | ﹤0.01% | 3743 |
|
|
2019
Q4 | $143K | Hold |
37,436
| – | – | ﹤0.01% | 3901 |
|
|
2019
Q3 | $146K | Hold |
37,436
| – | – | ﹤0.01% | 3867 |
|
|
2019
Q2 | $157K | Hold |
37,436
| – | – | ﹤0.01% | 3851 |
|
|
2019
Q1 | $256K | Buy |
37,436
+96
| +0.3% | +$598 | ﹤0.01% | 3662 |
|
|
2018
Q4 | $137K | Hold |
37,340
| – | – | ﹤0.01% | 3787 |
|
|
2018
Q3 | $236K | Buy |
37,340
+5,850
| +19% | +$40.9K | ﹤0.01% | 3717 |
|
|
2018
Q2 | $238K | Hold |
31,490
| – | – | ﹤0.01% | 3670 |
|
|
2018
Q1 | $251K | Hold |
31,490
| – | – | ﹤0.01% | 3618 |
|
|
2017
Q4 | $352K | Hold |
31,490
| – | – | ﹤0.01% | 3488 |
|
|
2017
Q3 | $364K | Sell |
31,490
-1
| -0% | -$9 | ﹤0.01% | 3459 |
|
|
2017
Q2 | $303K | Sell |
31,491
-490
| -2% | -$4.7K | ﹤0.01% | 3538 |
|
|
2017
Q1 | $373K | Buy |
31,981
+66
| +0.2% | +$669 | ﹤0.01% | 3422 |
|
|
2016
Q4 | $285K | Buy |
31,915
+44
| +0.1% | +$877 | ﹤0.01% | 3474 |
|
|
2016
Q3 | $1.04M | Buy |
31,871
+23,507
| +281% | +$572K | ﹤0.01% | 2919 |
|
|
2016
Q2 | $153K | Sell |
8,364
-28
| -0.3% | -$497 | ﹤0.01% | 3674 |
|
|
2016
Q1 | $139 | Sell |
8,392
-11
| -0.1% | -$220 | ﹤0.01% | 3740 |
|
|
2015
Q4 | $260K | Buy |
8,403
+3,053
| +57% | +$104K | ﹤0.01% | 3578 |
|
|
2015
Q3 | $277K | Buy |
+5,350
| New | +$352K | ﹤0.01% | 3522 |
|
Geode Capital Management's ALPN Position: Q2 2024 in Review
Geode Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 910,599 shares — an estimated $36.1M sold.
Geode Capital Management first reported a position in ALPN in Q3 2015 and held it in 35 quarters. The position peaked at $36.1M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Geode Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Geode Capital Management sold 910,599 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $36.1M.
- Geode Capital Management first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 35 quarters.
- Geode Capital Management's Alpine Immune Sciences Inc position peaked at $36.1M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.